Last 12 months
Inside the activity.
0 purchase rows · 9 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 20, 2021 Filed Sep 22, 2021 20:50 UTC |
Metzger Michael ADirector · President and COO
|
Exercise / conversionStock Options (Right to buy) · Derivative | 31,455 | $0.00 Strike: $7.20 | $0.00 |
DisclosureSEC source: 0001562180-21-006060 · primarydocument.xml · derivative · entry 7 Metzger Michael A · CIK 0001507220 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,455 shares Expires 2025-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is fully vested. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 20:50 UTC |
Metzger Michael ADirector · President and COO
|
SaleCommon Stock | 31,455 | $19.24 | $605,046.36 |
DisclosureSEC source: 0001562180-21-006060 · primarydocument.xml · nonDerivative · entry 2 Metzger Michael A · CIK 0001507220 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,659 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. F2 · price: The sale price ranged from $19.00 to $19.92 Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 20:50 UTC |
Metzger Michael ADirector · President and COO
|
Exercise / conversionCommon Stock | 31,455 | $7.20 | $226,476.00 |
DisclosureSEC source: 0001562180-21-006060 · primarydocument.xml · nonDerivative · entry 1 Metzger Michael A · CIK 0001507220 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,114 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 20:35 UTC |
Morrison BriggsDirector · Chief Executive Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 70,262 | $0.00 Strike: $7.20 | $0.00 |
DisclosureSEC source: 0001562180-21-006038 · primarydocument.xml · derivative · entry 5 Morrison Briggs · CIK 0001654430 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 70,262 shares Expires 2025-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 20:35 UTC |
Morrison BriggsDirector · Chief Executive Officer
|
SaleCommon Stock | 70,262 | $20.07 | $1,410,017.82 |
DisclosureSEC source: 0001562180-21-006038 · primarydocument.xml · nonDerivative · entry 2 Morrison Briggs · CIK 0001654430 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,336 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. F2 · price: The sale prices ranged from $20.00 to $20.32. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 20:35 UTC |
Morrison BriggsDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 70,262 | $7.20 | $505,886.40 |
DisclosureSEC source: 0001562180-21-006038 · primarydocument.xml · nonDerivative · entry 1 Morrison Briggs · CIK 0001654430 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:32 UTC |
Huber Martin H. Jr.Director
|
GrantStock Options (Right to buy) · Derivative | 35,000 | $19.36 Strike: $19.36 | $677,600.00 |
DisclosureSEC source: 0001562180-21-006002 · primarydocument.xml · derivative · entry 1 Huber Martin H. Jr. · CIK 0001653276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2031-09-15 F1 · derivative.exercise_date: 1/36th of the shares subject to the option shall vest monthly over a three-year period. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 20:16 UTC |
Metzger Michael ADirector · President and COO
|
Exercise / conversionStock Options (Right to buy) · Derivative | 44,349 | $0.00 Strike: $7.20 | $0.00 |
DisclosureSEC source: 0001562180-21-005948 · primarydocument.xml · derivative · entry 6 Metzger Michael A · CIK 0001507220 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 44,349 shares Expires 2025-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 20:16 UTC |
Metzger Michael ADirector · President and COO
|
SaleCommon Stock | 44,349 | $19.15 | $849,394.22 |
DisclosureSEC source: 0001562180-21-005948 · primarydocument.xml · nonDerivative · entry 4 Metzger Michael A · CIK 0001507220 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,659 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. F3 · price: The sale prices ranged from $19.00 to $19.31 Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 20:16 UTC |
Metzger Michael ADirector · President and COO
|
Exercise / conversionCommon Stock | 44,349 | $7.20 | $319,312.80 |
DisclosureSEC source: 0001562180-21-005948 · primarydocument.xml · nonDerivative · entry 3 Metzger Michael A · CIK 0001507220 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,008 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 20:16 UTC |
Metzger Michael ADirector · President and COO
|
Exercise / conversionStock Options (Right to buy) · Derivative | 16,651 | $0.00 Strike: $7.20 | $0.00 |
DisclosureSEC source: 0001562180-21-005948 · primarydocument.xml · derivative · entry 5 Metzger Michael A · CIK 0001507220 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,651 shares Expires 2025-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 20:16 UTC |
Metzger Michael ADirector · President and COO
|
SaleCommon Stock | 16,651 | $19.02 | $316,638.75 |
DisclosureSEC source: 0001562180-21-005948 · primarydocument.xml · nonDerivative · entry 2 Metzger Michael A · CIK 0001507220 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,659 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. F2 · price: The sale prices ranged from $19.00 to $19.10 Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 20:16 UTC |
Metzger Michael ADirector · President and COO
|
Exercise / conversionCommon Stock | 16,651 | $7.20 | $119,887.20 |
DisclosureSEC source: 0001562180-21-005948 · primarydocument.xml · nonDerivative · entry 1 Metzger Michael A · CIK 0001507220 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 20:32 UTC |
Egros FabriceDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 15,635 | $0.00 Strike: $7.88 | $0.00 |
DisclosureSEC source: 0001562180-21-005491 · primarydocument.xml · derivative · entry 3 Egros Fabrice · CIK 0001597085 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires 2029-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 20:32 UTC |
Egros FabriceDirector
|
SaleCommon Stock | 15,635 | $15.75 | $246,327.86 |
DisclosureSEC source: 0001562180-21-005491 · primarydocument.xml · nonDerivative · entry 2 Egros Fabrice · CIK 0001597085 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sale reported in this Form 4, the Reporting Person has a total of 77,682 options to purchase shares of common stock that are vested and immediately exercisable and a total of 0 options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $15.58 to $15.94. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 20:32 UTC |
Egros FabriceDirector
|
Exercise / conversionCommon Stock | 15,635 | $7.88 | $123,203.80 |
DisclosureSEC source: 0001562180-21-005491 · primarydocument.xml · nonDerivative · entry 1 Egros Fabrice · CIK 0001597085 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:46 UTC |
Egros FabriceDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 11,926 | $0.00 Strike: $7.20 | $0.00 |
DisclosureSEC source: 0001562180-21-003670 · primarydocument.xml · derivative · entry 6 Egros Fabrice · CIK 0001597085 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires 2025-08-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested. Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:46 UTC |
Egros FabriceDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 1,683 | $0.00 Strike: $7.88 | $0.00 |
DisclosureSEC source: 0001562180-21-003670 · primarydocument.xml · derivative · entry 5 Egros Fabrice · CIK 0001597085 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires 2029-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested. Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:46 UTC |
Egros FabriceDirector
|
SaleCommon Stock | 1,683 | $18.65 | $31,384.92 |
DisclosureSEC source: 0001562180-21-003670 · primarydocument.xml · nonDerivative · entry 4 Egros Fabrice · CIK 0001597085 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sale reported in this Form 4, the Reporting Person has a total of 93,317 options to purchase shares of common stock that are vested and immediately exercisable and a total of 0 options to purchase shares of common stock that have not yet vested. Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:46 UTC |
Egros FabriceDirector
|
SaleCommon Stock | 11,926 | $18.65 | $222,398.43 |
DisclosureSEC source: 0001562180-21-003670 · primarydocument.xml · nonDerivative · entry 3 Egros Fabrice · CIK 0001597085 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,683 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sale reported in this Form 4, the Reporting Person has a total of 93,317 options to purchase shares of common stock that are vested and immediately exercisable and a total of 0 options to purchase shares of common stock that have not yet vested. Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:46 UTC |
Egros FabriceDirector
|
Exercise / conversionCommon Stock | 1,683 | $7.88 | $13,262.04 |
DisclosureSEC source: 0001562180-21-003670 · primarydocument.xml · nonDerivative · entry 2 Egros Fabrice · CIK 0001597085 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,609 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:46 UTC |
Egros FabriceDirector
|
Exercise / conversionCommon Stock | 11,926 | $7.20 | $85,867.20 |
DisclosureSEC source: 0001562180-21-003670 · primarydocument.xml · nonDerivative · entry 1 Egros Fabrice · CIK 0001597085 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2021 Filed Apr 28, 2021 20:15 UTC |
Meyers Michael L.SVP, Chief Medical Officer
|
PurchaseCommon Stock | 500 | $15.46 | $7,730.00 |
DisclosureSEC source: 0001562180-21-002976 · primarydocument.xml · nonDerivative · entry 1 Meyers Michael L. · CIK 0001664204 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,666 Read SEC document |
| April 22, 2021 Filed Apr 22, 2021 17:06 UTC |
Podlesak DennisDirector
|
PurchaseCommon Stock | 13,967 | $14.11 | $197,077.16 |
DisclosureSEC source: 0001562180-21-002912 · primarydocument.xml · nonDerivative · entry 1 Podlesak Dennis · CIK 0001314595 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,300 F1 · price: The purchase prices ranged from $13.98 to $14.29. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:16 UTC |
Egros FabriceDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 10,167 | $0.00 Strike: $6.35 | $0.00 |
DisclosureSEC source: 0001562180-21-001909 · primarydocument.xml · derivative · entry 6 Egros Fabrice · CIK 0001597085 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:16 UTC |
Egros FabriceDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 74 | $0.00 Strike: $7.20 | $0.00 |
DisclosureSEC source: 0001562180-21-001909 · primarydocument.xml · derivative · entry 5 Egros Fabrice · CIK 0001597085 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires 2025-08-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:16 UTC |
Egros FabriceDirector
|
SaleCommon Stock | 74 | $24.31 | $1,799.10 |
DisclosureSEC source: 0001562180-21-001909 · primarydocument.xml · nonDerivative · entry 4 Egros Fabrice · CIK 0001597085 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sale reported in this Form 4, the Reporting Person has a total of 106,926 options to purchase shares of common stock that are vested and immediately exercisable and a total of 0 options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $23.84 to $25.15. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:16 UTC |
Egros FabriceDirector
|
SaleCommon Stock | 10,167 | $24.31 | $247,182.14 |
DisclosureSEC source: 0001562180-21-001909 · primarydocument.xml · nonDerivative · entry 3 Egros Fabrice · CIK 0001597085 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,074 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sale reported in this Form 4, the Reporting Person has a total of 106,926 options to purchase shares of common stock that are vested and immediately exercisable and a total of 0 options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $23.84 to $25.15. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:16 UTC |
Egros FabriceDirector
|
Exercise / conversionCommon Stock | 74 | $7.20 | $532.80 |
DisclosureSEC source: 0001562180-21-001909 · primarydocument.xml · nonDerivative · entry 2 Egros Fabrice · CIK 0001597085 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:16 UTC |
Egros FabriceDirector
|
Exercise / conversionCommon Stock | 10,167 | $6.35 | $64,560.45 |
DisclosureSEC source: 0001562180-21-001909 · primarydocument.xml · nonDerivative · entry 1 Egros Fabrice · CIK 0001597085 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 21:23 UTC |
Morrison BriggsDirector · Chief Executive Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 35,156 | $0.00 Strike: $7.20 | $0.00 |
DisclosureSEC source: 0001562180-21-001044 · primarydocument.xml · derivative · entry 3 Morrison Briggs · CIK 0001654430 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,156 shares Expires 2025-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 21:23 UTC |
Morrison BriggsDirector · Chief Executive Officer
|
SaleCommon Stock | 35,156 | $20.55 | $722,403.07 |
DisclosureSEC source: 0001562180-21-001044 · primarydocument.xml · nonDerivative · entry 2 Morrison Briggs · CIK 0001654430 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,336 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule10b5-1 plan adopted by the Reporting Person. Following the sale reported in this Form 4, the Reporting Person has a total of 1,161,507 options to purchase shares of common stock that are vested and immediately exercisable and a total of 518,334 options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $20.00 to $20.93. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 21:23 UTC |
Morrison BriggsDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 35,156 | $7.20 | $253,123.20 |
DisclosureSEC source: 0001562180-21-001044 · primarydocument.xml · nonDerivative · entry 1 Morrison Briggs · CIK 0001654430 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 21:22 UTC |
Karydas DaphneChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 95,000 | $0.00 Strike: $21.36 | $0.00 |
DisclosureSEC source: 0001562180-21-000933 · primarydocument.xml · derivative · entry 1 Karydas Daphne · CIK 0001816952 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 95,000 shares Expires 2031-02-03 F1 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly over a four-year period. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 21:18 UTC |
Jarrett JenniferDirector
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000926 · primarydocument.xml · nonDerivative · entry 1 Jarrett Jennifer · CIK 0001671311 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 F1 · shares: Award of Restricted Stock Units that vests one year from the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the earlier of a separation from service, death, disability or change in control. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 16:18 UTC |
Podlesak DennisDirector
|
GrantCommon Stock | 29,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000930 · primarydocument.xml · nonDerivative · entry 1 Podlesak Dennis · CIK 0001314595 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,333 F1 · shares: Award of Restricted Stock Units that vests one year from the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the earlier of a separation from service, death, disability or change in control. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 21:18 UTC |
Katkin KeithDirector
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000927 · primarydocument.xml · nonDerivative · entry 1 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 F1 · shares: Award of Restricted Stock Units that vests one year from the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the earlier of a separation from service, death, disability or change in control. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 16:18 UTC |
Legault PierreDirector
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000928 · primarydocument.xml · nonDerivative · entry 1 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 F1 · shares: Award of Restricted Stock Units that vests one year from the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the earlier of a separation from service, death, disability or change in control. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 21:22 UTC |
Metzger Michael ADirector · President and COO
|
GrantStock Option (Right to Buy) · Derivative | 160,000 | $0.00 Strike: $21.36 | $0.00 |
DisclosureSEC source: 0001562180-21-000935 · primarydocument.xml · derivative · entry 1 Metzger Michael A · CIK 0001507220 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2031-02-03 F1 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly over a four-year period. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 21:22 UTC |
Ordentlich PeterChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $21.36 | $0.00 |
DisclosureSEC source: 0001562180-21-000934 · primarydocument.xml · derivative · entry 1 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2031-02-03 F1 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly over a four-year period. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 21:21 UTC |
Morrison BriggsDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 195,000 | $0.00 Strike: $21.36 | $0.00 |
DisclosureSEC source: 0001562180-21-000932 · primarydocument.xml · derivative · entry 2 Morrison Briggs · CIK 0001654430 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,000 Underlying: Common Stock · 195,000 shares Expires 2031-02-03 F2 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly over a four-year period. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 21:21 UTC |
Meyers Michael L.SVP, Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $21.36 | $0.00 |
DisclosureSEC source: 0001562180-21-000931 · primarydocument.xml · derivative · entry 3 Meyers Michael L. · CIK 0001664204 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2031-02-03 F3 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly over a four-year period. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 21:18 UTC |
Egros FabriceDirector
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000925 · primarydocument.xml · nonDerivative · entry 1 Egros Fabrice · CIK 0001597085 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 F1 · shares: Award of Restricted Stock Units that vests one year from the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the earlier of a separation from service, death, disability or change in control. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 21:18 UTC |
Meury WilliamDirector
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000929 · primarydocument.xml · nonDerivative · entry 1 Meury William · CIK 0001536778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 F1 · shares: Award of Restricted Stock Units that vests one year from the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the earlier of a separation from service, death, disability or change in control. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 22:53 UTC |
Metzger Michael ADirector · President and COO
|
Exercise / conversionStock Options (Right to buy) · Derivative | 15,000 | $0.00 Strike: $7.20 | $0.00 |
DisclosureSEC source: 0001562180-21-000869 · primarydocument.xml · derivative · entry 3 Metzger Michael A · CIK 0001507220 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2025-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 22:53 UTC |
Metzger Michael ADirector · President and COO
|
SaleCommon Stock | 15,000 | $20.19 | $302,799.00 |
DisclosureSEC source: 0001562180-21-000869 · primarydocument.xml · nonDerivative · entry 2 Metzger Michael A · CIK 0001507220 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,659 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sale reported in this Form 4, the Reporting Person has a total of 732,490 options to purchase shares of common stock that are vested and immediately exercisable and a total of 343,750 options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $20.00 to $20.44. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 22:53 UTC |
Metzger Michael ADirector · President and COO
|
Exercise / conversionCommon Stock | 15,000 | $7.20 | $108,000.00 |
DisclosureSEC source: 0001562180-21-000869 · primarydocument.xml · nonDerivative · entry 1 Metzger Michael A · CIK 0001507220 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,659 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2021 Filed Feb 5, 2021 21:21 UTC |
Morrison BriggsDirector · Chief Executive Officer
|
OtherCommon Stock | 1,771 | $12.00 | $21,252.00 |
DisclosureSEC source: 0001562180-21-000932 · primarydocument.xml · nonDerivative · entry 1 Morrison Briggs · CIK 0001654430 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,336 F1 · kind: The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 1,771 shares by the Reporting Person on 01/31/2021 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| January 31, 2021 Filed Feb 5, 2021 21:21 UTC |
Meyers Michael L.SVP, Chief Medical Officer
|
OtherCommon Stock | 1,771 | $12.00 | $21,252.00 |
DisclosureSEC source: 0001562180-21-000931 · primarydocument.xml · nonDerivative · entry 2 Meyers Michael L. · CIK 0001664204 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,166 F2 · kind: The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 1,771 shares by the Reporting Person on 01/31/2021 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 23:05 UTC |
Metzger Michael ADirector · President and COO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $7.20 | $0.00 |
DisclosureSEC source: 0001562180-20-007070 · primarydocument.xml · derivative · entry 3 Metzger Michael A · CIK 0001507220 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2025-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.